Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950124-96-002047
Filing Date
1996-05-10
Accepted
1996-05-10 00:00:00
Documents
3
Period of Report
1995-12-31

Document Format Files

Seq Description Document Type Size
1 10-K 10-K 156743
2 CALCULATION OF EARNINGS PER SHARE EX-11.1 2341
3 FINANCIAL DATA SCHEDULE EX-27 2096
  Complete submission text file 0000950124-96-002047.txt   162837
Mailing Address C/O WILSON SONSIN GOODRICH & ROSETI 650 PAGE MILL ROAD PALO ALTO CA 94304
Business Address 225 EAST DEERPATH STE 250 LAKE FOREST IL 60045 7082958678
NEOPHARM INC (Filer) CIK: 0000942788 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26898 | Film No.: 96559994
SIC: 8731 Services-Commercial Physical & Biological Research